Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination of Clinically Utilized Kappa‐Opioid Receptor Agonist Nalfurafine With Low‐Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice
Yan Zhou, Mary Jeanne Kreek
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 6, pp. 1077-1090
Open Access | Times Cited: 21

Showing 21 citing articles:

The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Martin L. Dalefield, Brittany Scouller, Rabia Bibi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 60
Dynorphin and its role in alcohol use disorder
Anushree N. Karkhanis, Ream Al‐Hasani
Brain Research (2020) Vol. 1735, pp. 146742-146742
Open Access | Times Cited: 40
Kappa opioid receptors in the bed nucleus of the stria terminalis regulate binge-like alcohol consumption in male and female mice
Harold L. Haun, William C. Griffin, Marcelo F. Lopez, et al.
Neuropharmacology (2020) Vol. 167, pp. 107984-107984
Open Access | Times Cited: 32
Systematic Structure–Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management Treatments
Celsey M. St. Onge, Piyusha P. Pagare, Yi Zheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9552-9574
Open Access | Times Cited: 3
Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological Effects
Danni Cao, Peng Huang, Yi-Ting Chiu, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 19, pp. 3036-3050
Open Access | Times Cited: 23
Systemic kappa opioid receptor antagonism accelerates reinforcement learning via augmentation of novelty processing in male mice
Zahra Z. Farahbakhsh, Keaton Song, Hannah E. Branthwaite, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 6, pp. 857-868
Open Access | Times Cited: 7
Fluorescence-guided resection of tumors in mouse models of oral cancer
Paula Demétrio De Souza França, Navjot Guru, Sheryl Roberts, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist
Yan Zhou, Kevin B. Freeman, Vincent Setola, et al.
Handbook of experimental pharmacology (2021), pp. 137-162
Open Access | Times Cited: 16
Endogenous opiates and behavior: 2019
Richard J. Bodnar
Peptides (2021) Vol. 141, pp. 170547-170547
Closed Access | Times Cited: 15
Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice
Amelia Dunn, Kyle A. Windisch, Ariel Ben-Ezra, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2405-2418
Closed Access | Times Cited: 15
Signaling underlying kappa opioid receptor-mediated behaviors in rodents
Lee‐Yuan Liu‐Chen, Peng Huang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 9
Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice
Yan Zhou, Mary Jeanne Kreek
Brain Research (2019) Vol. 1724, pp. 146410-146410
Open Access | Times Cited: 14
LOW-DOSE NALTREXONE REVERSES FACIAL MECHANICAL ALLODYNIA IN A RAT MODEL OF TRIGEMINAL NEURALGIA
Camila Lino de Oliveira, Liciane Fernandes Medeiros, Vanessa Silva de Souza, et al.
Neuroscience Letters (2020) Vol. 736, pp. 135248-135248
Closed Access | Times Cited: 14
Sex- and β-arrestin-dependent effects of kappa opioid receptor-mediated ethanol consumption
Alexander R. French, Anna M. Gutridge, Jinling Yuan, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 216, pp. 173377-173377
Open Access | Times Cited: 5
mTORC1 pathway is involved in the kappa opioid receptor activation-induced increase in excessive alcohol drinking in mice
Yan Zhou, Yupu Liang, Mary Jeanne Kreek
Pharmacology Biochemistry and Behavior (2020) Vol. 195, pp. 172954-172954
Open Access | Times Cited: 5
Kappa Opioid Receptors and Mu Opioid Receptors as Combined Targets for Medication Development for Alcoholism
Yan Zhou, Mary Jeanne Kreek
Biological Psychiatry (2019) Vol. 86, Iss. 11, pp. 809-810
Closed Access | Times Cited: 4
Blockade of alcohol excessive and “relapse” drinking in male mice by pharmacological cryptochrome (CRY) activation
Yan Zhou, Mary Jeanne Kreek
Psychopharmacology (2021) Vol. 238, Iss. 4, pp. 1099-1109
Open Access | Times Cited: 4
Limitations and potential of κOR biased agonists for pain and itch management
Amal El Daibani, Manish K. Madasu, Ream Al‐Hasani, et al.
Neuropharmacology (2024) Vol. 258, pp. 110061-110061
Closed Access
Emerging GPCR targets for AUD: Insights from preclinical studies
Roberta G. Anversa, Maiya L. Barron, Leigh C. Walker, et al.
Current Opinion in Neurobiology (2024) Vol. 87, pp. 102896-102896
Open Access
Involvement of GRK2 in modulating nalfurafine-induced reduction of excessive alcohol drinking in mice
Yan Zhou, Yupu Liang
Neuroscience Letters (2021) Vol. 760, pp. 136092-136092
Open Access | Times Cited: 3
The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis
Yan Zhou
Journal of Pharmaceutics & Pharmacology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top